Close
Dr. Mikael Dolsten, former Chief Scientist at Pfizer, joins Immunai's board of directors. His extensive experience in drug and vaccine development, including the first COVID-19 vaccine, positions him to significantly contribute to Immunai's mission. The integration of AI in immunology and oncology is expected to drive innovation in drug development.
Immunai's AI model is transforming drug discovery by analyzing immune system activity at the single-cell level. Dolsten's collaboration with Immunai aims to enhance the efficiency and success rates of drug development. The company's partnerships with AstraZeneca and Teva further emphasize the importance of AI-driven insights in clinical development.
• Immunai's AI model enhances drug discovery and development efficiency.
• Dolsten's expertise will drive innovation in AI applications for drug development.
Artificial Intelligence is utilized to analyze immune system activity and improve drug development processes.
Drug Development refers to the process of bringing new drugs to market, enhanced by AI insights.
Single-Cell Analysis involves examining individual cells to understand immune responses, crucial for targeted therapies.
Immunai specializes in AI-based immune system mapping technology to accelerate drug discovery.
Pfizer is a leading pharmaceutical company known for its extensive drug and vaccine development efforts.
Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600
How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.
Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.
Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.
Log in
Sign Up
AI Tools - Popular
AI Tools - Categories
GPTs - Categories
AI for Jobs
Key AI Highlights in this Article
Key AI Terms Mentioned in this Article
Companies Mentioned in this Article
